Selective Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Selective Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-225	Closed	-$2K	–	665
2022 Q3	$2K	Sell	225 -200	-47%	-$1.77K	﹤0.01%	691
2022 Q2	$3K	Hold	425	–	–	﹤0.01%	680
2022 Q1	$4K	Hold	425	–	–	﹤0.01%	620
2021 Q4	$3K	Hold	425	–	–	﹤0.01%	592
2021 Q3	$4K	Hold	425	–	–	﹤0.01%	511
2021 Q2	$4K	Hold	425	–	–	﹤0.01%	426
2021 Q1	$5K	Hold	425	–	–	﹤0.01%	316
2020 Q4	$4K	Hold	425	–	–	﹤0.01%	309
2020 Q3	$4K	Hold	425	–	–	﹤0.01%	257
2020 Q2	$5K	Hold	425	–	–	﹤0.01%	308
2020 Q1	$4K	Hold	425	–	–	0.01%	229
2019 Q4	$4K	Hold	425	–	–	﹤0.01%	248
2019 Q3	$3K	Buy	+425	New	+$3.26K	﹤0.01%	275
2018 Q3	$9K	Buy	+425	New	+$9.87K	0.11%	94

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Selective Wealth Management's TEVA Position: Q4 2022 in Review

Selective Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 225 shares — an estimated $2K sold.

Selective Wealth Management first reported a position in TEVA in Q3 2018 and held it in 14 quarters. The position peaked at $9K in Q3 2018. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

Selective Wealth Management reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Selective Wealth Management sold 225 Teva Pharmaceuticals shares in Q4 2022, an estimated $2K.
Selective Wealth Management first reported a position in Teva Pharmaceuticals in Q3 2018 and held it in 14 quarters.
Selective Wealth Management's Teva Pharmaceuticals position peaked at $9K in Q3 2018.
422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Selective Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.